Wesfarmers Ltd's $1 billion capital return and distribution: What you need to know

Wesfarmers Limited (ASX:WES) is rewarding shareholders with special dividends and a capital return after a strong year and the sale of its insurance business.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Retailing and industrial conglomerate Wesfarmers Ltd (ASX: WES) recently reported a strong full year result and capped the good news off by announcing a $1 billion capital management distribution plan for shareholders.

A final dividend of $1.05 was declared in addition to a 10 cent per share "centenary" special dividend to celebrate being in business for over 100 years.

A special distribution was also declared, due in part to the strong cash flow generated during FY 2014. Wesfarmers also enjoyed the proceeds of selling its insurance businesses.

For shareholders and investors interested in buying stock in Wesfarmers, here is what you need to know about the special distribution.

Distribution components:  The capital management distribution will be an extra $1 per share. 65% – 75% of the $1 is expected to represent the capital component. The remaining balance will be a fully-franked dividend component.

The capital component is subject to shareholder approval. In addition, it will be dependent on a ruling from the ATO. It is expected the ATO ruling in relation to taxation treatment will be received before the AGM on 20 November when shareholders will consider the proposal.

Receipt of distribution: If all conditions are met, shareholders are expected to receive payments in December 2014.

Capital component conversion ratio: The share consolidation's conversion ratio will reflect the size of the capital component. The ratio will be based on the volume weighted average sale price of Wesfarmers' shares over the consecutive 20 trading day period ending 18 August 2014, which is $43.29.

Motley Fool contributor Darryl Daté-Shappard does not own shares in any company mentioned. 

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »